The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AEGLEA BIOTHERAPEUTICS INC COM 00773J103 2,587 279,678 SH   SOLE 0 279,678 0 0
AMGEN INC COM 031162100 853 3,615 SH   SOLE 0 3,615 0 0
APOLLO ENDOSURGERY INC COM 03767D108 456 279,037 SH   SOLE 0 279,037 0 0
LEXICON PHARMACEUTICALS INC COM 528872302 71 35,714 SH   SOLE 0 35,714 0 0
PLX PHARMA INC COM 72942A107 203 62,673 SH   SOLE 0 62,673 0 0
PORTLAND GENERAL ELECTRIC CO COM 736508847 5 118 SH   SOLE 0 118 0 0
SOLITON INC COM 834251100 3,307 425,000 SH   SOLE 0 425,000 0 0
SQUARE INC COM 852234103 52 500 SH   SOLE 0 500 0 0
STRYKER CORP COM 863667101 685 3,800 SH   SOLE 0 3,800 0 0
TEXAS INSTRUMENTS INC COM 882508104 4,063 32,000 SH   SOLE 0 32,000 0 0
VANGUARD TOTAL WORLD STOCK ETF ETFS 922042742 13,581 181,558 SH   SOLE 0 181,558 0 0